Tag: J. Kevin Duplechain

All

The American Academy of Cosmetic Surgery (AACS) successfully held its Annual Scientific Meeting on February 3-5, 2022, in Las Vegas.

If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.